The nutritional induction of COUP-TFII gene expression in ventromedial hypothalamic neurons is mediated by the melanocortin pathway

PLoS ONE

Volumn 5, Issue 10, 2010, Pages

  Sabra Makke, Lina ^a   Tourrel Cuzin, Cécile ^b   Denis, Raphaël G P ^b   Moldes, Marthe ^a   Pégorier, Jean Paul ^a   Luquet, Serge ^b   Vasseur Cognet, Mireille ^a   Bossard, Pascale ^a  

^a INSTITUT COCHIN   (France)

^b Groupe Hospitalier Pitié Salpêtrière   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CHICKEN OVALBUMIN UPSTREAM PROMOTER TRANSCRIPTION FACTOR 2; CYCLIC AMP; INSULIN; MELANOCORTIN; MELANOCORTIN RECEPTOR; MESSENGER RNA; NR2F2 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL SUBPOPULATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; GENE EXPRESSION REGULATION; GENE LOCATION; HORMONE ACTION; HYPOINSULINEMIA; INSULIN RESPONSE; LIVER; MALE; MOUSE; NERVE CELL; NONHUMAN; NUTRITIONAL STATUS; PANCREAS; TISSUE DISTRIBUTION; TRANSCRIPTION INITIATION; UPREGULATION; ZONA INCERTA; ANIMAL; C57BL MOUSE; FLUORESCENT ANTIBODY TECHNIQUE; GENETICS; HYPOTHALAMUS; METABOLISM; PROMOTER REGION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

MUS;

ANIMALS; COUP TRANSCRIPTION FACTOR II; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION REGULATION; HYPOTHALAMUS; MELANOCORTINS; MICE; MICE, INBRED C57BL; NEURONS; PROMOTER REGIONS, GENETIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSCRIPTIONAL ACTIVATION;

EID: 78149434173     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0013464     Document Type: Article

References (56)

1. Spiegelman BM, Flier JS (2001) Obesity and the regulation of energy balance. Cell 104: 531-543.
2. Obici S, Rossetti L (2003) Minireview: nutrient sensing and the regulation of insulin action and energy balance. Endocrinology 144: 5172-5178.
3. Benoit G, Cooney A, Giguere V, Ingraham H, Lazar M, et al. (2006) International Union of Pharmacology. LXVI. Orphan nuclear receptors. Pharmacol Rev 58: 798-836.
4. Sugiyama T, Wang JC, Scott DK, Granner DK (2000) Transcription activation by the orphan nuclear receptor, chicken ovalbumin upstream promotertranscription factor I (COUP-TFI). Definition of the domain involved in the glucocorticoid response of the phosphoenolpyruvate carboxykinase gene. J Biol Chem 275: 3446-3454.
5. Cooney AJ, Lee CT, Lin SC, Tsai SY, Tsai MJ (2001) Physiological function of the orphans GCNF and COUP-TF. Trends Endocrinol Metab 12: 247-251.
6. Lee CT, Li L, Takamoto N, Martin JF, Demayo FJ, et al. (2004) The nuclear orphan receptor COUP-TFII is required for limb and skeletal muscle development. Mol Cell Biol 24: 10835-10843.
7. Perilhou A, Tourrel-Cuzin C, Kharroubi I, Henique C, Fauveau V, et al. (2008) The transcription factor COUP-TFII is negatively regulated by insulin and glucose via Foxo1- and ChREBP-controlled pathways. Mol Cell Biol 28: 6568-6579.
8. Bardoux P, Zhang P, Flamez D, Perilhou A, Lavin TA, et al. (2005) Essential role of chicken ovalbumin upstream promoter-transcription factor II in insulin secretion and insulin sensitivity revealed by conditional gene knockout. Diabetes 54: 1357-1363.
9. Myers SA, Wang SC, Muscat GE (2006) The chicken ovalbumin upstream promoter-transcription factors modulate genes and pathways involved in skeletal muscle cell metabolism. Journal of Biological Chemistry 281: 24149-24160.
10. Li L, Xie X, Qin J, Jeha GS, Saha PK, et al. (2009) The nuclear orphan receptor COUP-TFII plays an essential role in adipogenesis, glucose homeostasis, and energy metabolism. Cell Metab 9: 77-87.
11. Yamamoto M, Fujinuma M, Tanaka M, Drager UC, McCaffery P (1999) Sagittal band expression of COUP-TF2 gene in the developing cerebellum. Mech Dev 84: 143-146.
12. Kurrasch DM, Cheung CC, Lee FY, Tran PV, Hata K, et al. (2007) The neonatal ventromedial hypothalamus transcriptome reveals novel markers with spatially distinct patterning. J Neurosci 27: 13624-13634.
13. Jonk LJ, de Jonge ME, Pals CE, Wissink S, Vervaart JM, et al. (1994) Cloning and expression during development of three murine members of the COUP family of nuclear orphan receptors. Mech Dev 47: 81-97.
14. Fuentealba P, Klausberger T, Karayannis T, Suen WY, Huck J, et al. (2010) Expression of COUP-TFII nuclear receptor in restricted GABAergic neuronal populations in the adult rat hippocampus. J Neurosci 30: 1595-1609.
15. Friedman JM (2000) Obesity in the new millennium. Nature 404: 632-634.
16. Elmquist JK, Coppari R, Balthasar N, Ichinose M, Lowell BB (2005) Identifying hypothalamic pathways controlling food intake, body weight, and glucose homeostasis. J Comp Neurol 493: 63-71.
17. Porte D, Jr., Baskin DG, Schwartz MW (2002) Leptin and insulin action in the central nervous system. Nutr Rev 60: S20-29; discussion S68-84,85-27.
18. Lou DQ, Tannour M, Selig L, Thomas D, Kahn A, et al. (1999) Chicken ovalbumin upstream promoter-transcription factor II, a new partner of the glucose response element of the L-type pyruvate kinase gene, acts as an inhibitor of the glucose response. Journal of Biological Chemistry 274: 28385-28394.
19. Björklund A, Hökfelt T, Swanson LW (1987) Integrated Systems of the CNS, Part I (Hypothalamus, hippocampus, amygdala, retina); Björklund A, Hökfelt T, Swanson LW, eds. Amsterdam: Elsevier. 495 p.
20. Tomassy GS, De Leonibus E, Jabaudon D, Lodato S, Alfano C, et al. (2010) Area-specific temporal control of corticospinal motor neuron differentiation by COUP-TFI. Proc Natl Acad Sci U S A 107: 3576-3581.
21. Dhillon H, Zigman JM, Ye C, Lee CE, McGovern RA, et al. (2006) Leptin directly activates SF1 neurons in the VMH, and this action by leptin is required for normal body-weight homeostasis. Neuron 49: 191-203.
22. Tong Q, Ye C, McCrimmon RJ, Dhillon H, Choi B, et al. (2007) Synaptic glutamate release by ventromedial hypothalamic neurons is part of the neurocircuitry that prevents hypoglycemia. Cell Metab 5: 383-393.
23. Majdic G, Young M, Gomez-Sanchez E, Anderson P, Szczepaniak LS, et al. (2002) Knockout mice lacking steroidogenic factor 1 are a novel genetic model of hypothalamic obesity. Endocrinology 143: 607-614.
24. Unger TJ, Calderon GA, Bradley LC, Sena-Esteves M, Rios M (2007) Selective deletion of Bdnf in the ventromedial and dorsomedial hypothalamus of adult mice results in hyperphagic behavior and obesity. J Neurosci 27: 14265-14274.
25. Fu LY, van den Pol AN (2008) Agouti-related peptide and MC3/4 receptor agonists both inhibit excitatory hypothalamic ventromedial nucleus neurons. J Neurosci 28: 5433-5449.
26. Benoit SC, Air EL, Coolen LM, Strauss R, Jackman A, et al. (2002) The catabolic action of insulin in the brain is mediated by melanocortins. J Neurosci 22: 9048-9052.
27. Mountjoy KG, Mortrud MT, Low MJ, Simerly RB, Cone RD (1994) Localization of the melanocortin-4 receptor (MC4-R) in neuroendocrine and autonomic control circuits in the brain. Mol Endocrinol 8: 1298-1308.
28. Magenis RE, Smith L, Nadeau JH, Johnson KR, Mountjoy KG, et al. (1994) Mapping of the ACTH, MSH, and neural (MC3 and MC4) melanocortin receptors in the mouse and human. Mamm Genome 5: 503-508.
29. Khong K, Kurtz SE, Sykes RL, Cone RD (2001) Expression of functional melanocortin-4 receptor in the hypothalamic GT1-1 cell line. Neuroendocrinology 74: 193-201.
30. Gantz I, Miwa H, Konda Y, Shimoto Y, Tashiro T, et al. (1993) Molecular cloning, expression, and gene localization of a fourth melanocortin receptor. Journal of Biological Chemistry 268: 15174-15179.
31. Soosaar A, Neuman K, Nornes HO, Neuman T (1996) Cell type specific regulation of COUP-TF II promoter activity. FEBS Lett 391: 95-100.
32. Xu B, Goulding EH, Zang K, Cepoi D, Cone RD, et al. (2003) Brain-derived neurotrophic factor regulates energy balance downstream of melanocortin-4 receptor. Nat Neurosci 6: 736-742.
33. Nicholson JR, Peter JC, Lecourt AC, Barde YA, Hofbauer KG (2007) Melanocortin-4 receptor activation stimulates hypothalamic brain-derived neurotrophic factor release to regulate food intake, body temperature and cardiovascular function. J Neuroendocrinol 19: 974-982.
34. Zhou L, Sutton GM, Rochford JJ, Semple RK, Lam DD, et al. (2007) Serotonin 2C receptor agonists improve type 2 diabetes via melanocortin-4 receptor signaling pathways. Cell Metab 6: 398-405.
35. Obici S, Feng Z, Tan J, Liu L, Karkanias G, et al. (2001) Central melanocortin receptors regulate insulin action. J Clin Invest 108: 1079-1085.
36. Toda C, Shiuchi T, Lee S, Yamato-Esaki M, Fujino Y, et al. (2009) Distinct effects of leptin and a melanocortin receptor agonist injected into medial hypothalamic nuclei on glucose uptake in peripheral tissues. Diabetes 58: 2757-2765.
37. Hetherington AW, Ranson SW (1983) Nutrition classics. The anatomical record, Volume 78, 1940. Hypothalamic lesions and adiposity in rats. Nutr Rev 41: 124-127.
38. Borg MA, Sherwin RS, Borg WP, Tamborlane WV, Shulman GI (1997) Local ventromedial hypothalamus glucose perfusion blocks counterregulation during systemic hypoglycemia in awake rats. J Clin Invest 99: 361-365.
39. van Houten M, Posner BI (1979) Insulin binds to brain blood vessels in vivo. Nature 282: 623-625.
40. Torsoni MA, Carvalheira JB, Pereira-Da-Silva M, Carvalho-Filho MA, Saad MJ, et al. (2003) Molecular and functional resistance to insulin in hypothalamus of rats exposed to cold. Am J Physiol Endocrinol Metab 285: E216-E223.
41. Niswender KD, Baskin DG, Schwartz MW (2004) Insulin and its evolving partnership with leptin in the hypothalamic control of energy homeostasis. Trends EndocrinolMetab 15: 362-369.
42. Sato I, Arima H, Ozaki N, Watanabe M, Goto M, et al. (2005) Insulin inhibits neuropeptide Y gene expression in the arcuate nucleus through GABAergic systems. J Neurosci 25: 8657-8664.
43. Minokoshi Y, Alquier T, Furukawa N, Kim YB, Lee A, et al. (2004) AMP-kinase regulates food intake by responding to hormonal and nutrient signals in the hypothalamus. Nature 428: 569-574.
44. Lerner RG, Depatie C, Rutter GA, Screaton RA, Balthasar N (2009) A role for the CREB co-activator CRTC2 in the hypothalamic mechanisms linking glucose sensing with gene regulation. EMBO Rep 10: 1175-1181.
45. Huszar D, Lynch CA, Fairchild-Huntress V, Dunmore JH, Fang Q, et al. (1997) Targeted disruption of the melanocortin-4 receptor results in obesity in mice. Cell 88: 131-141.
46. Vaisse C, Clement K, Guy-Grand B, Froguel P (1998) A frameshift mutation in human MC4R is associated with a dominant form of obesity [letter]. Nat Genet 20: 113-114.
47. Vaisse C, Clement K, Durand E, Hercberg S, Guy-Grand B, et al. (2000) Melanocortin-4 receptor mutations are a frequent and heterogeneous cause of morbid obesity. J Clin Invest 106: 253-262.
48. Yeo GS, Farooqi IS, Challis BG, Jackson RS, O'Rahilly S (2000) The role of melanocortin signalling in the control of body weight: evidence from human and murine genetic models. QJM 93: 7-14.
49. Fan W, Dinulescu DM, Butler AA, Zhou J, Marks DL, et al. (2000) The central melanocortin system can directly regulate serum insulin levels. Endocrinology 141: 3072-3079.
50. Kublaoui BM, Holder JL, Jr., Tolson KP, Gemelli T, Zinn AR (2006) SIM1 overexpression partially rescues agouti yellow and diet-induced obesity by normalizing food intake. Endocrinology 147: 4542-4549.
51. Kublaoui BM, Holder JL, Jr., Gemelli T, Zinn AR (2006) Sim1 haploinsufficiency impairs melanocortin-mediated anorexia and activation of paraventricular nucleus neurons. Mol Endocrinol 20: 2483-2492.
52. Mellon PL, Windle JJ, Goldsmith PC, Padula CA, Roberts JL, et al. (1990) Immortalization of hypothalamic GnRH neurons by genetically targeted tumorigenesis. Neuron 5: 1-10.
53. Perilhou A, Tourrel-Cuzin C, Zhang P, Kharroubi I, Wang H, et al. (2008) The MODY1 gene for hepatocyte nuclear factor 4alpha and a feedback loop control COUP-TFII expression in pancreatic beta cells. Mol Cell Biol 28: 4588-4597.
54. Bobard A, Hainault I, Ferre P, Foufelle F, Bossard P (2005) Differential regulation of sterol regulatory element-binding protein 1c transcriptional activity by insulin and liver X receptor during liver development. Journal of Biological Chemistry 280: 199-206.
55. Bossard P, Zaret KS (1998) GATA transcription factors as potentiators of gut endoderm differentiation. Development 125: 4909-4917.
56. Kluver H, Barrera E (1953) A method for the combined staining of cells and fibers in the nervous system. J Neuropathol Exp Neurol 12: 400-403.